Dr. Nakahara has been engaged in technological development of in vivo imaging diagnosis using nuclear medicine. He is also working to improve quantitation of radiotracers accumulated in target lesions, with the aim for clinical application of apply alpha- or beta-emitting probes to radionuclide therapy.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)